New methods for deriving macrophages from induced pluripotent stem cells are easier to scale and provide more clinically relevant data. Induced pluripotent stem cells (iPSCs) have given scientists ...

SmartCella and Catalent have entered a nonexclusive license agreement for induced pluripotent stem cells (iPSCs) for developing regenerative therapies ...

Flow cytometers, droplet dispensers, and limiting dilution techniques aimed at depositing a single iPSC in a well, often create a strenuous and unnatural environment that leads to low clonal survival ...

Induced pluripotent stem cells (iPSCs) have emerged from the general stem cell controversies of the early 2000s to offer potential cures for significant degenerative diseases. “We are the world’s ...

Since Shinya Yamanaka (Kyoto University, Japan) detailed the process through which somatic cells can be reprogrammed to a pluripotent stem-cell state, the applications of these induced pluripotent ...

Japanese researchers have transplanted human induced pluripotent stem cells (iPSCs) in a primate model of myocardial infarction and were able to restore heart muscle and function in monkeys. Developed ...

The world’s second-ever private astronaut mission to the International Space Station will not only ferry up the first Saudi Arabian woman to go to space but also a first-of-its-kind experiment that ...

Introducing our In Focus on iPSCs for cell and gene therapies, this video explores the history of iPSCs, their adaptability and the workflow for their inclusion in the development of cell and gene ...

From the beginning, stem cell research has presented hope for patients living with a range of diseases, from cancer to type 1 diabetes to Parkinson’s disease. The limiting factor has been the ...